Usually 1 tablet/day, but refer to pack for instructions Postpartum (not breastfeeding) – commence at 3 weeks’ postpartum – there is an increased risk of DVT if commenced earlier – patient must be fully ambulant, with no puerperal complications, and be counselled for the risk of DVT Breastfeeding – not recommended until weaning or at least 6 months if unable to obtain other contraception Miscarriage or abortion – commence on same day if possible
Route of admin
Oral
Contraindications
Pregnancy, migraine, liver disease including cholestatic jaundice, history of pruritus in pregnancy, breastfeeding, prothrombotic coagulation disorders, previous history or strong familial history of DVT, undiagnosed vaginal bleeding, breast or genital tract carcinoma CAUTION: arterial disease, smoking, hypertension, obesity, diabetes mellitus with retinopathy and nephropathy, ischaemic heart disease, varicosities, depression, inflammatory bowel disease, Rotor syndrome, Dubin–Johnson syndrome, sickle cell anaemia, history of herpes gestationis, disorders of lipid metabolism Stop prior to major surgery or surgery to the legs, or with long-term immobilization – do not stop for minor surgery with short anaesthetic duration, e.g. laparoscopy or tooth extraction
Side effects
Nausea, vomiting, headache, breast tenderness, changes in body weight, libido changes, DVT, intracycle bleeding, amenorrhoea, decreased menstrual bleeding, depression, impaired liver function
Interactions
Antibiotics – broad spectrum – reduce effect Anticoagulants – antagonizes the effect of warfarin Antidepressants – tricyclics – antagonizes the antidepressant effects but increases the side effects because of the increased plasma concentration of tricyclics Antidiabetics – antagonism of the hypoglycaemic effect Antiepileptics – carbamazepine, phenobarbital and phenytoin accelerate metabolism and reduce contraceptive effect Antihypertensives – antagonize hypotensive effect
Pharmacodynamic properties
The combination of these preparations acts to inhibit ovulation by suppressing the mid-cycle surge of luteinizing hormone, thickening the cervical mucus as a barrier to sperm, and rendering the endometrium unresponsive to implantation
Fetal risk
Evidence suggests no harmful effects to fetus, although there is teratogenicity in animals (US studies have found a small risk of 0.07% of all pregnancies exposed to the oral contraceptive pill)
Breastfeeding
Suppressed lactation; contraindicated until at least 6 months after birth
Contraception, alternative to oestrogens – higher failure rate, suitable in smokers, hypertension, valvular heart disease, diabetes mellitus, migraine, predisposition to or history of thrombosis or venous thrombosis
Type of drug
POM
Presentation
Tablets in cyclical packs
Dosage
Usually 1 tablet/day, but refer to pack instructions – must be taken at the same time each day postpartum – commence after 3 weeks – breakthrough bleeding if earlier – women should also be aware of the increased risk of thromboembolic disorders
Route of admin
Oral
Contraindications
Pregnancy, undiagnosed vaginal bleeding, severe arterial disease, existing thrombophlebitis or thromboembolic disorders, cerebrovascular disease, porphyria, heart disease including myocardial infarction, malabsorption syndromes, liver disease, sex steroid-dependent cancers, past ectopic pregnancy, functional ovarian cysts, cholestatic jaundice, pruritus of pregnancy, Dubin–Johnson syndrome, Rotor syndrome, history of herpes gestationis, disorders of lipid metabolism
Side effects
Menstrual irregularities, nausea, vomiting, menstrual symptoms, weight change, depression, dizziness, loss of libido, headaches, chloasma
Interactions
Antibiotics – rifamycins – increase metabolism and therefore reduce effect Anticoagulants – antagonize effect of warfarin Antidiabetics – antagonize the hypoglycaemic effects Antiepileptics – reduce contraceptive effect St John’s wort – can lead to potential loss of contraceptive effect